• May 16, 2021

Opinion: STAT+: Three steps toward creating a functioning U.S. biosimilars market

The development of safe, effective, and innovative biologic medicines is one of modern medicine’s far-reaching achievements. From cancer and colitis to rheumatoid arthritis, biologics have transformed many severe diseases into treatable conditions for millions of people.

Unlike so-called small-molecule drugs, like aspirin or a cholesterol-lowering statin, which are normally developed by synthesizing chemicals with well-defined structures, biologics are derived from complex living organisms. Current biologics are administered either by infusion under a doctor’s supervision or by injection, which can be done in a doctor’s office or at home.

Continue to STAT+ to read the full story…

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Related post